Day One Biopharmaceuticals I shares owned by UBS Group
Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Day One Biopharmaceuticals I
Tip: Access up to 7 years of quarterly data
All positions including Day One Biopharmaceuticals I held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Day One Biopharmaceuticals I by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.8M | 127k | 14.60 |
| 2023-09-30 | $293k | 24k | 12.27 |
| 2023-06-30 | $150k | 13k | 11.93 |
| 2023-03-31 | $934k | 70k | 13.37 |
| 2022-12-31 | $2.8M | 130k | 21.52 |
| 2022-09-30 | $366k | 22k | 16.95 |
| 2022-06-30 | $69k | 3.9k | 17.92 |
| 2021-12-31 | $104k | 6.1k | 16.97 |
| 2021-09-30 | $1.0k | 59 | 16.95 |